Herbal drug based adjuvant therapy effective in treating diabetic Covid-19 patients: Researchers – more way of life


Anti-oxidative herbal medicines with evidence-based useful impacts in the remedy of diabetes can be utilized as an adjuvant therapy to the conventional remedy of diabetic Covid-19 patients, according to researchers in Tehran. The researchers, then again, famous that better designed experimental and clinical studies are urgently required to confirm their recommended effects. In a review published in the National Centre for Biotechnology Information (NCBI), they said “anti-oxidative herbal medicines can be utilized as adjuvant to currently prescribed drugs to treat coronavirus in patients with diabetes and also can also be regarded as as a suitable source to identify novel therapeutic agents for Covid-19”.

“Sure herbs work as antioxidants and check free radicals except maintaining normal blood glucose levels,” A K S Rawat, former senior scientist with CSIR- National Botanical Research Institute (NBRI), said.

He also referred to anti-diabetic herbal formulation, BGR-34, developed the use of extracts of herbs like Giloy, Vijaysar, Daruharidra, Gudmar, Methika and Majeeth.

The formulation has been scientifically developed by NBRI in collaboration with the Central Institute for Medicinal and Fragrant Plant (CIMAP), both Lucknow-based CSIR labs.

BGR-34, commercially manufactured by Aimil Pharmaceuticals, has shown therapeutic efficacy for treating newly diagnosed kind 2 diabetes, as found in independent clinical trials conducted at Banaras Hindu University (BHU), Varanasi final year. As the world observes November 14 as Diabetes Day, Rawat also said that herbal ingredients like Giloy used in BGR-34 also corrects immunity, while compounds in Dharuharida help in insulin release in kind 2 diabetic patients.

Based on the 2019 International Diabetes Federation (IDF) outline, the world prevalence of diabetes was once 463 million, and is expected to succeed in 578 million in 2030, and 700 million in 2045.

According to doctors, patients with co-morbidities like diabetes are more vulnerable to coronavirus on account of their compromised immunity.

Top stories / News


Please enter your comment!
Please enter your name here